Effects of Macroplastique((R)) Implantation System for stress urinary incontinence and urethral hypermobility in women.
Author(s): Ter Meulen PH, Berghmans LC, Nieman FH, van Kerrebroeck PE
Affiliation(s): Department of Urology, University Hospital Maastricht, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands, firstname.lastname@example.org.
Publication date & source: 2008-10-21, Int Urogynecol J Pelvic Floor Dysfunct., [Epub ahead of print]
A study was carried out to evaluate efficacy of Macroplastique(R) (MPQ) Implantation System (MIS) in women with urodynamic stress urinary incontinence (SUI) and urethral hypermobility after an unsuccessful conservative treatment. This is a prospective randomized controlled trial in women without previous incontinence surgery. Twenty-four women received MPQ. Twenty-one controls underwent a pelvic floor muscle exercises home program. Follow-up was at 3 months and the MPQ group also at 12 months. At 3 months, pad usage decreased significantly more in the MPQ group than in the control group (p = 0.015). According to physician and patient self-assessment, respectively, 71% and 63% women in the MPQ group were considered cured or markedly improved. This was significantly higher compared to controls. There was a significant higher increase of Incontinence Quality-of-Life questionnaire score in the MPQ group compared to controls (p = 0.017). Improvements in MPQ group at 3 months are sustained to 12 months. Adverse events were mild and transient. MIS is an acceptable option for women with SUI and urethral hypermobility.